386 related articles for article (PubMed ID: 15879305)
1. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase.
Münzel T; Daiber A; Ullrich V; Mülsch A
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1551-7. PubMed ID: 15879305
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension.
Schulz E; Jansen T; Wenzel P; Daiber A; Münzel T
Antioxid Redox Signal; 2008 Jun; 10(6):1115-26. PubMed ID: 18321209
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.
Mollnau H; Wendt M; Szöcs K; Lassègue B; Schulz E; Oelze M; Li H; Bodenschatz M; August M; Kleschyov AL; Tsilimingas N; Walter U; Förstermann U; Meinertz T; Griendling K; Münzel T
Circ Res; 2002 Mar; 90(4):E58-65. PubMed ID: 11884382
[TBL] [Abstract][Full Text] [Related]
4. NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in BKbeta1-/- mice.
Oelze M; Warnholtz A; Faulhaber J; Wenzel P; Kleschyov AL; Coldewey M; Hink U; Pongs O; Fleming I; Wassmann S; Meinertz T; Ehmke H; Daiber A; Münzel T
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1753-9. PubMed ID: 16763163
[TBL] [Abstract][Full Text] [Related]
5. Vasomotor control in mice overexpressing human endothelial nitric oxide synthase.
van Deel ED; Merkus D; van Haperen R; de Waard MC; de Crom R; Duncker DJ
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1144-53. PubMed ID: 17496213
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells.
Mollnau H; Schulz E; Daiber A; Baldus S; Oelze M; August M; Wendt M; Walter U; Geiger C; Agrawal R; Kleschyov AL; Meinertz T; Münzel T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):615-21. PubMed ID: 12692005
[TBL] [Abstract][Full Text] [Related]
7. Effects of 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on smooth muscle tone, soluble guanylyl cyclase activity, and NADPH oxidase activity/expression in corpus cavernosum from wild-type, neuronal, and endothelial nitric-oxide synthase null mice.
Teixeira CE; Priviero FB; Webb RC
J Pharmacol Exp Ther; 2007 Sep; 322(3):1093-102. PubMed ID: 17596536
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
Lee NP; Cheng CY
Endocrinology; 2003 Jul; 144(7):3114-29. PubMed ID: 12810568
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
[TBL] [Abstract][Full Text] [Related]
10. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
[TBL] [Abstract][Full Text] [Related]
11. Understanding eNOS for pharmacological modulation of endothelial function: a translational view.
Braam B; Verhaar MC
Curr Pharm Des; 2007; 13(17):1727-40. PubMed ID: 17584103
[TBL] [Abstract][Full Text] [Related]
12. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta.
Mülsch A; Oelze M; Klöss S; Mollnau H; Töpfer A; Smolenski A; Walter U; Stasch JP; Warnholtz A; Hink U; Meinertz T; Münzel T
Circulation; 2001 May; 103(17):2188-94. PubMed ID: 11331261
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of increased vascular superoxide production in an experimental model of idiopathic dilated cardiomyopathy.
Mollnau H; Oelze M; August M; Wendt M; Daiber A; Schulz E; Baldus S; Kleschyov AL; Materne A; Wenzel P; Hink U; Nickenig G; Fleming I; Münzel T
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2554-9. PubMed ID: 16224052
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction.
Münzel T; Sinning C; Post F; Warnholtz A; Schulz E
Ann Med; 2008; 40(3):180-96. PubMed ID: 18382884
[TBL] [Abstract][Full Text] [Related]
15. Effect of hypercholesterolemia and of oxidative stress on the nitric oxide-cGMP pathway.
Francois M; Kojda G
Neurochem Int; 2004 Nov; 45(6):955-61. PubMed ID: 15312990
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
17. Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases.
Dupont LL; Glynos C; Bracke KR; Brouckaert P; Brusselle GG
Pulm Pharmacol Ther; 2014 Oct; 29(1):1-6. PubMed ID: 25043200
[TBL] [Abstract][Full Text] [Related]
18. Molecular variants of soluble guanylyl cyclase affecting cardiovascular risk.
Wobst J; Rumpf PM; Dang TA; Segura-Puimedon M; Erdmann J; Schunkert H
Circ J; 2015; 79(3):463-9. PubMed ID: 25746521
[TBL] [Abstract][Full Text] [Related]
19. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment.
Schulz E; Tsilimingas N; Rinze R; Reiter B; Wendt M; Oelze M; Woelken-Weckmüller S; Walter U; Reichenspurner H; Meinertz T; Münzel T
Circulation; 2002 Mar; 105(10):1170-5. PubMed ID: 11889009
[TBL] [Abstract][Full Text] [Related]
20. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
